213 related articles for article (PubMed ID: 24218296)
21. Clinical and histological correlation of diabetic nephropathy.
Afroz T; Sagar R; Reddy S; Gandhe S; Rajaram KG
Saudi J Kidney Dis Transpl; 2017; 28(4):836-841. PubMed ID: 28748886
[TBL] [Abstract][Full Text] [Related]
22. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
23. Diabetic nephropathy.
Rabkin R
Clin Cornerstone; 2003; 5(2):1-11. PubMed ID: 12800476
[TBL] [Abstract][Full Text] [Related]
24. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.
Fioretto P; Caramori ML; Mauer M
Diabetologia; 2008 Aug; 51(8):1347-55. PubMed ID: 18528679
[TBL] [Abstract][Full Text] [Related]
25. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
[TBL] [Abstract][Full Text] [Related]
26. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1127-1150. PubMed ID: 31586514
[TBL] [Abstract][Full Text] [Related]
27. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.
Niewczas MA; Sirich TL; Mathew AV; Skupien J; Mohney RP; Warram JH; Smiles A; Huang X; Walker W; Byun J; Karoly ED; Kensicki EM; Berry GT; Bonventre JV; Pennathur S; Meyer TW; Krolewski AS
Kidney Int; 2014 May; 85(5):1214-24. PubMed ID: 24429397
[TBL] [Abstract][Full Text] [Related]
28. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy.
Burger AJ; D'Elia JA; Weinrauch LA; Lerman I; Gaur A
Int J Cardiol; 2002 Dec; 86(2-3):281-7. PubMed ID: 12419567
[TBL] [Abstract][Full Text] [Related]
29. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
30. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
Mulec H; Blohmé G; Grände B; Björck S
Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
[TBL] [Abstract][Full Text] [Related]
31. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
[TBL] [Abstract][Full Text] [Related]
32. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress.
Perkins BA; Krolewski AS
Curr Diab Rep; 2005 Dec; 5(6):455-63. PubMed ID: 16316598
[TBL] [Abstract][Full Text] [Related]
33. Clinical manifestations and natural history of diabetic kidney disease.
Ritz E
Med Clin North Am; 2013 Jan; 97(1):19-29. PubMed ID: 23290727
[TBL] [Abstract][Full Text] [Related]
34. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
35. Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.
van der Sande NG; Dorresteijn JA; Visseren FL; Dwyer JP; Blankestijn PJ; van der Graaf Y; Heerspink HL
Diabetes Obes Metab; 2016 Nov; 18(11):1120-1127. PubMed ID: 27337598
[TBL] [Abstract][Full Text] [Related]
36. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
[TBL] [Abstract][Full Text] [Related]
37. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
Fried LF; Duckworth W; Zhang JH; O'Connor T; Brophy M; Emanuele N; Huang GD; McCullough PA; Palevsky PM; Seliger S; Warren SR; Peduzzi P;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):361-8. PubMed ID: 19118120
[TBL] [Abstract][Full Text] [Related]
38. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
39. Renal function in recipients of pancreas transplant alone.
Smail N; Paraskevas S; Tan X; Metrakos P; Cantarovich M
Curr Opin Organ Transplant; 2012 Feb; 17(1):73-9. PubMed ID: 22186098
[TBL] [Abstract][Full Text] [Related]
40. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
Skupien J; Smiles AM; Valo E; Ahluwalia TS; Gyorgy B; Sandholm N; Croall S; Lajer M; McDonnell K; Forsblom C; Harjutsalo V; Marre M; Galecki AT; Tregouet DA; Wu CY; Mychaleckyj JC; Nickerson H; Pragnell M; Rich SS; Pezzolesi MG; Hadjadj S; Rossing P; Groop PH; Krolewski AS
Diabetes Care; 2019 Jan; 42(1):93-101. PubMed ID: 30455333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
